Synopsis
Synopsis
0
CEP/COS
0
KDMF
0
VMF
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. 2 Mercaptopropionylglycine
2. 2 Thiol Propionamido Acetic Acid
3. 2 Thiolpropionamidoacetic Acid
4. 2-mercaptopropionylglycine
5. 2-thiol-propionamido-acetic Acid
6. 2-thiolpropionamidoacetic Acid
7. Acadione
8. Acid, 2-thiol-propionamido-acetic
9. Acid, 2-thiolpropionamidoacetic
10. Alpha Mercaptopropionylglycine
11. Alpha-mercaptopropionylglycine
12. Captimer
13. Meprin
14. Mercaptopropionylglycine
15. Thiola
16. Thiopronine
17. Tiopronine
1. 1953-02-2
2. N-(2-mercaptopropionyl)glycine
3. Acadione
4. Captimer
5. Thiopronine
6. Mucolysin
7. Capen
8. Thiola
9. Tiopronine
10. Epatiol
11. 2-(2-sulfanylpropanoylamino)acetic Acid
12. Thiosol
13. Glycine, N-(2-mercapto-1-oxopropyl)-
14. Tiopronin (thiola)
15. A-mercaptopropionyl Glycine
16. 2-(2-mercaptopropanamido)acetic Acid
17. Nsc-760416
18. Chembl1314
19. C5w04go61s
20. N-(2-mercaptopropanoyl)glycine
21. Thiopronin
22. Chebi:32229
23. 2-(2-sulfanylpropanamido)acetic Acid
24. Ncgc00159422-02
25. Ncgc00159422-04
26. Sutilan
27. Dsstox_cid_3678
28. Glycine, N-(2-mercapto-1-oxopropyl)- (9ci)
29. Dsstox_rid_77142
30. Dsstox_gsid_23678
31. Thiolpropionamidoacetic Acid
32. Tioglis
33. Vincol
34. Cas-1953-02-2
35. Meprin (detoxicant)
36. N-(2-mercapto-1-oxopropyl)glycine
37. Tiopronine [inn-french]
38. Tioproninum [inn-latin]
39. Tiopronino [inn-spanish]
40. (2-mercaptopropionyl)glycine
41. Tiopronin [inn:dcf:jan]
42. Tiopronino
43. Tioproninum
44. Ccris 1935
45. (s)-2-(2-mercaptopropanamido)acetic Acid
46. Einecs 217-778-4
47. Thiola (tn)
48. Brn 1859822
49. Thiola Ec
50. Tiopronin (jan/inn)
51. Tiopronin [inn]
52. Tiopronin [jan]
53. Tiopronin [mi]
54. Glycine, N-(2-mercaptopropionyl)-
55. Tiopronin [vandf]
56. 2-mercapto-propionylglycine
57. Tiopronin [mart.]
58. Tiopronin [who-dd]
59. (2-mercaptopropanoyl)glycine
60. Unii-c5w04go61s
61. Schembl19989
62. Mls006010632
63. Alpha-mercaptopropionyl Glycine
64. Mercaptopropionylglycine-
65. N-(2-sulfanylpropanoyl)glycine
66. Tiopronin [orange Book]
67. Dtxsid4023678
68. N-(2-mercaptopropionyl) Glycine
69. N-(2-mercaptopropanoyl) Glycine
70. Acadione; Capen; Epatiol; Vincol
71. Hms3264b11
72. Hms3655l15
73. Pharmakon1600-01506190
74. Amy39003
75. Bcp13354
76. Hy-b0373
77. 2-(2-mercaptopropanamido)aceticacid
78. Tox21_111654
79. Bdbm50020805
80. Mfcd00004861
81. Mfcd30157366
82. Nsc760416
83. S2062
84. (2-mercaptopropionylamino)acetic Acid
85. Akos015895408
86. N-(2-mercaptopropionyl)glycine, 99%
87. Tox21_111654_1
88. Ac-2087
89. Ccg-214007
90. Db06823
91. Nsc 760416
92. (2-mercapto-propionylamino)-acetic Acid
93. Ncgc00159422-03
94. As-12522
95. Smr001550282
96. Sy262996
97. Ft-0603530
98. Ft-0653686
99. Sw219206-1
100. T2614
101. Tiopronin, Vetranal(tm), Analytical Standard
102. C73708
103. D01430
104. Ab00376096_02
105. 953t022
106. A813794
107. Q414456
108. Sr-01000942263
109. J-012651
110. Sr-01000942263-1
111. Tiopronin, Dextiopronin, Tiopronin (n-2-mercaptopropionyl Glycine)
Molecular Weight | 163.20 g/mol |
---|---|
Molecular Formula | C5H9NO3S |
XLogP3 | -0.1 |
Hydrogen Bond Donor Count | 3 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 3 |
Exact Mass | 163.03031432 g/mol |
Monoisotopic Mass | 163.03031432 g/mol |
Topological Polar Surface Area | 67.4 Ų |
Heavy Atom Count | 10 |
Formal Charge | 0 |
Complexity | 148 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Tiopronin is indicated for the prevention of kidney stone formation in patients with severe homozygous cystinuria consisting of a urinary cystine concentration greater than 500 mg/day, and who have failed treatment with non-pharmacological measures of increased fluid intake, decreased sodium and protein intake, and urine alkalinization.
G - Genito urinary system and sex hormones
G04 - Urologicals
G04B - Urologicals
G04BX - Other urologicals
G04BX16 - Tiopronin
Absorption
Tiopronin undergoes slow absorption, reaching peak plasma concentration 3-6 hours after ingestion. In a study of healthy subjects, the bioavailability of total and unbound tiopronin was found to be 63% and 40%, respectively.
Route of Elimination
Tiopronin is 100% excreted in urine.
Volume of Distribution
The volume of distribution of tiopronin is high at 455 L, indicating that a large portion of the drug is bound to tissues outside plasma.
Clearance
Total renal clearance for the total and unbound fractions of tiopronin were found to be 3.3 and 13.3 L/h respectively.
The principle metabolite of tiopronin is 2-mercaptopropionic acid (2-MPA). Between 10-15% of the drug is metabolized to 2-MPA via hydrolysis.
Tiopronin has a long terminal half life of 53 hours in healthy subjects. However, the unbound drug fraction of tiopronin is eliminated much more rapidly from plasma with a calculated half life of 1.8 hours.
Kidney stones form when the solubility limit is exceeded and urine becomes supersaturated with endogenous cystine. Tiopronin is an active reducing agent which undergoes a thiol-disulfide exchange with cystine to form a water-soluble mixed disulfide complex. Thus, the amount of sparingly soluble cystine is reduced. By reducing urinary cystine concentrations below the solubility limit, tiopronin helps reduce cystine stone formation.
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Tiopronin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tiopronin, including repackagers and relabelers. The FDA regulates Tiopronin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tiopronin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Tiopronin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Tiopronin supplier is an individual or a company that provides Tiopronin active pharmaceutical ingredient (API) or Tiopronin finished formulations upon request. The Tiopronin suppliers may include Tiopronin API manufacturers, exporters, distributors and traders.
click here to find a list of Tiopronin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Tiopronin DMF (Drug Master File) is a document detailing the whole manufacturing process of Tiopronin active pharmaceutical ingredient (API) in detail. Different forms of Tiopronin DMFs exist exist since differing nations have different regulations, such as Tiopronin USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Tiopronin DMF submitted to regulatory agencies in the US is known as a USDMF. Tiopronin USDMF includes data on Tiopronin's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Tiopronin USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Tiopronin suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Tiopronin Drug Master File in Japan (Tiopronin JDMF) empowers Tiopronin API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Tiopronin JDMF during the approval evaluation for pharmaceutical products. At the time of Tiopronin JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Tiopronin suppliers with JDMF on PharmaCompass.
A Tiopronin written confirmation (Tiopronin WC) is an official document issued by a regulatory agency to a Tiopronin manufacturer, verifying that the manufacturing facility of a Tiopronin active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Tiopronin APIs or Tiopronin finished pharmaceutical products to another nation, regulatory agencies frequently require a Tiopronin WC (written confirmation) as part of the regulatory process.
click here to find a list of Tiopronin suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Tiopronin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Tiopronin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Tiopronin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Tiopronin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Tiopronin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Tiopronin suppliers with NDC on PharmaCompass.
Tiopronin Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tiopronin GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tiopronin GMP manufacturer or Tiopronin GMP API supplier for your needs.
A Tiopronin CoA (Certificate of Analysis) is a formal document that attests to Tiopronin's compliance with Tiopronin specifications and serves as a tool for batch-level quality control.
Tiopronin CoA mostly includes findings from lab analyses of a specific batch. For each Tiopronin CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tiopronin may be tested according to a variety of international standards, such as European Pharmacopoeia (Tiopronin EP), Tiopronin JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tiopronin USP).
LOOKING FOR A SUPPLIER?